{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "AUD", "marketState": "POSTPOST", "regularMarketChangePercent": 4.0404005, "regularMarketPrice": 1.03, "exchange": "ASX", "shortName": "PARA BIO FPO", "longName": "Paradigm Biopharmaceuticals Limited", "messageBoardId": "finmb_276414891", "exchangeTimezoneName": "Australia/Sydney", "exchangeTimezoneShortName": "AEST", "gmtOffSetMilliseconds": 36000000, "market": "au_market", "esgPopulated": false, "regularMarketTime": 1683871827, "earningsTimestamp": 1682655861, "earningsTimestampStart": 1682655861, "earningsTimestampEnd": 1682655861, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.15, "epsForward": 0.04, "sharesOutstanding": 282094016, "bookValue": 0.261, "fiftyDayAverage": 1.2143, "fiftyDayAverageChange": -0.18430007, "fiftyDayAverageChangePercent": -0.15177473, "twoHundredDayAverage": 1.3720088, "twoHundredDayAverageChange": -0.34200883, "twoHundredDayAverageChangePercent": -0.24927597, "marketCap": 296425760, "forwardPE": 25.75, "priceToBook": 3.9463599, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1439942400000, "priceHint": 4, "regularMarketChange": 0.03999996, "regularMarketDayHigh": 1.035, "regularMarketDayRange": "1.0 - 1.035", "regularMarketDayLow": 1.0, "regularMarketVolume": 269998, "regularMarketPreviousClose": 0.99, "bid": 1.02, "ask": 1.03, "bidSize": 0, "askSize": 0, "fullExchangeName": "ASX", "financialCurrency": "AUD", "regularMarketOpen": 1.005, "averageDailyVolume3Month": 723866, "averageDailyVolume10Day": 414380, "fiftyTwoWeekLowChange": 0.17499995, "fiftyTwoWeekLowChangePercent": 0.2046783, "fiftyTwoWeekRange": "0.855 - 2.154315", "fiftyTwoWeekHighChange": -1.124315, "fiftyTwoWeekHighChangePercent": -0.5218898, "fiftyTwoWeekLow": 0.855, "fiftyTwoWeekHigh": 2.154315, "symbol": "PAR.AX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "500 Collins Street", "address2": "Level 15", "city": "Melbourne", "state": "VIC", "zip": "3000", "country": "Australia", "phone": "61 3 9629 5566", "fax": "61 3 9629 5466", "website": "https://www.paradigmbiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC", "age": 63, "title": "Founder, MD & Exec. Chairman", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 697025, "fmt": "697.02k", "longFmt": "697,025"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Donna L. Skerrett M.D., MS", "age": 65, "title": "Chief Medical Officer and Exec. Director", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": {"raw": 1102605, "fmt": "1.1M", "longFmt": "1,102,605"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Abby  Macnish Niven B.Com., B.Sc., C.F.A.", "title": "Interim Company Sec., Interim CFO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ravi  Krishnan", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Simon  White", "title": "Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Imperiale", "title": "Global Head of Drug Safety & MPS", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Beverley  Huttmann", "title": "Commercial Head", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Michelle  Coffey", "title": "Global Head of Regulatory Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mukesh  Ahuja", "title": "Global Clinical Head of OA", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 1, "overallRisk": 8, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}